These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8554958)

  • 1. Deaths associated with warfarin in elderly patients.
    Reardon M; Burns B; Brewer B; O'Sullivan JP
    Br J Clin Pract; 1995; 49(6):322-3. PubMed ID: 8554958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of warfarin therapy in the nursing home setting.
    Gurwitz JH; Field TS; Radford MJ; Harrold LR; Becker R; Reed G; DeBellis K; Moldoff J; Verzier N
    Am J Med; 2007 Jun; 120(6):539-44. PubMed ID: 17524757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin prevalence, indications for use and haemorrhagic events.
    Ouirke W; Cahill M; Perera K; Sargent J; Conway J
    Ir Med J; 2007 Mar; 100(3):402-4. PubMed ID: 17491542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic anticoagulation in the trauma patient: is it safe?
    Golob JF; Sando MJ; Kan JC; Yowler CJ; Malangoni MA; Claridge JA
    Surgery; 2008 Oct; 144(4):591-6; discussion 596-7. PubMed ID: 18847643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics.
    White RH; McKittrick T; Takakuwa J; Callahan C; McDonell M; Fihn S
    Arch Intern Med; 1996 Jun; 156(11):1197-201. PubMed ID: 8639014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The necessity to assess anticoagulation status in elderly injured patients.
    Williams TM; Sadjadi J; Harken AH; Victorino GP
    J Trauma; 2008 Oct; 65(4):772-6; discussion 776-7. PubMed ID: 18849789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of levofloxacin in elderly patients on warfarin.
    Stroud LF; Mamdami MM; Kopp A; Bell CM
    Am J Med; 2005 Dec; 118(12):1417. PubMed ID: 16378802
    [No Abstract]   [Full Text] [Related]  

  • 10. Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tay KH; Lip GY; Lane DA
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):392-3. PubMed ID: 19542940
    [No Abstract]   [Full Text] [Related]  

  • 11. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
    Abdelhafiz AH; Wheeldon NM
    Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
    Garwood CL; Corbett TL
    Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancies in identification of major bleeding events in patients taking warfarin.
    Seto AC; Kenyon K; Wittkowsky AK
    Pharmacotherapy; 2008 Sep; 28(9):1098-103. PubMed ID: 18752380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of long-term oral anticoagulation in a non-trial medical environment.
    McKenna CJ; Galvin J; McCann HA; Sugrue DD
    Ir Med J; 1996; 89(4):144-5. PubMed ID: 8824039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.
    Jacobs LG
    Cardiol Clin; 2008 May; 26(2):157-67, v. PubMed ID: 18406992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy.
    Varkarakis IM; Rais-Bahrami S; Allaf ME; Lima GC; Permpongkosol S; Rao P; Jarrett TW; Kavoussi LR
    J Urol; 2005 Sep; 174(3):1020-3; discussion 1023. PubMed ID: 16094036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter regarding article by Hylek et al, "Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation".
    Ono A; Kawamura I; Fujita T
    Circulation; 2007 Nov; 116(20):e538. PubMed ID: 17998467
    [No Abstract]   [Full Text] [Related]  

  • 19. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.
    Jacobs LG
    Clin Geriatr Med; 2006 Feb; 22(1):17-32, vii-viii. PubMed ID: 16377465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of hemorrhage among patients with warfarin-associated coagulopathy.
    Garcia DA; Regan S; Crowther M; Hylek EM
    J Am Coll Cardiol; 2006 Feb; 47(4):804-8. PubMed ID: 16487849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.